What are the key drivers for decision making in drug development?
The pharmaceutical industry and basic research depend on robust data and scientific rigor as key drivers for decision making. They determine the pace of knowledge gain and ultimately the time needed to make new drug treatments available to patients.
What factors impact the transition from preclinical to clinical testing?
Recent publications report challenges with regard to the robustness, rigor and validity of research data, which often impact the transition from preclinical to clinical testing.
How can we improve innovation and data quality to speed up drug development?
We seek to provide simple and sustainable solutions that facilitate data quality without impacting innovation and freedom of research. Our consortium will pool resources from both academia and industry to pilot this action in neuroscience and drug safety with applicability beyond these research areas.